ClinicalTrials.Veeva

Menu
L

Lääkärikeskus Gyneko | Oulu, Finland

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Vilaprisan
BAY3427080
Elinzanetant
BAY1128688
Drospirenone
Estetrol Monohydrate
BAY1817080

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 7 total trials

A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer (OASIS-4)

Researchers are looking for a better way to treat women with, or at high risk for developing hormone-receptor positive breast cancer, who have vasomo...

Active, not recruiting
Hot Flashes
Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer
Drug: Placebo
Drug: Elinzanetant (BAY3427080)

The study was performed to assess the efficacy and safety of Vilaprisan in subjects with uterine fibroids compared to standard of care

Active, not recruiting
Uterine Fibroids
Drug: Vilaprisan (BAY1002670)
Other: Standard of care

Trial sponsors

Bayer logo
E

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems